Semitendinosus Autograft vs Meniscal Allograft in Post-Meniscectomy Syndrome
NCT07204587 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-10-02
Summary
This multicenter, stratified, partially randomized clinical trial aims to compare autologous semitendinosus tendon graft and meniscal allograft transplantation (MAT) in young adults with post-meniscectomy syndrome. The meniscus plays a critical role in load distribution, shock absorption, and joint stability. After meniscectomy, insufficient meniscal tissue often leads to persistent pain, swelling, and functional decline, increasing the risk of early osteoarthritis.
Two reconstructive strategies are clinically available: MAT provides immediate biomechanical function but requires donor matching and carries higher costs, while autologous tendon graft offers stable supply and no immunologic risk but lacks long-term clinical validation.
In this study, 40 patients aged 18-45 years will be enrolled. Participants will be allocated into four groups (randomized MAT, randomized autograft, patient-preference MAT, patient-preference autograft). All procedures will use a two-tunnel fixation technique with additional internal brace support.
The primary endpoint is the improvement in KOOS (Knee Injury and Osteoarthritis Outcome Score) at 24 months postoperatively. Secondary endpoints include MRI-based assessment of graft morphology and extrusion, reoperation rate, complications, patient satisfaction, and return-to-sport time.
This trial will provide critical evidence regarding the comparative effectiveness and feasibility of tendon autograft versus meniscal allograft in real-world clinical settings, potentially informing surgical decision-making and future treatment guidelines for post-meniscectomy syndrome.
Conditions
- Meniscal Injuries
- Meniscal Tear
- Meniscus Lesion
Interventions
- PROCEDURE
-
Autologous Semitendinosus Tendon Graft
Meniscal reconstruction will be performed using autologous semitendinosus tendon harvested from the ipsilateral leg. The graft diameter must be at least 6 mm. A two-tunnel fixation technique will be employed, securing the graft to the tibial plateau at the anatomic meniscal root sites. The graft will be shaped and positioned to mimic the native meniscal contour. Fibertape internal brace augmentation will be added to enhance fixation strength and graft stability. If concomitant anterior cruciate ligament reconstruction is indicated, the graft choice and ACL technique will be determined by the surgeon, without restriction. Postoperative rehabilitation will follow a standardized protocol across all centers.
- PROCEDURE
-
Meniscal Allograft Transplantation (MAT)
Meniscal allograft transplantation will use size-matched, fresh-frozen allograft menisci prepared according to institutional tissue bank standards. Grafts will be fixed using a two-tunnel bone plug technique, restoring the anatomic root insertions. The allograft will be centrally positioned within the tibiofemoral compartment, and centralization sutures may be added at the discretion of the operating surgeon. All procedures will be standardized across participating centers, and postoperative rehabilitation protocols will be identical to those used in the autologous graft arm.
Sponsors & Collaborators
-
Karolinska University Hospital
collaborator OTHER -
Chang Gung Memorial Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-01
- Primary Completion
- 2028-09-30
- Completion
- 2029-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Clinical Effect of Allogeneic Meniscus Transplantation
NCT04960436 ·Status: COMPLETED ·Phase: NA
-
The Benefit of Arthroscopic Partial Meniscectomy in Middle-Aged Patients
NCT01264991 ·Status: TERMINATED ·Phase: NA
-
A Study on Different Treatments for Knee Osteoarthritis Caused by Damaged Roots of the Medial Meniscus.
NCT06707948 ·Status: NOT_YET_RECRUITING
-
Evaluation on Safety and Effectiveness of the An All-inside, All-suture Meniscal Repair Device
NCT06899659 ·Status: COMPLETED ·Phase: NA
-
Operative vs Non-operative Management of Posterior-medial Meniscal Root Tears: A Randomized Multicenter Trial (RCT)
NCT05985772 ·Status: RECRUITING ·Phase: NA
-
Study of Meniscal Allografts
NCT01059409 ·Status: TERMINATED ·Phase: NA
-
Knee Articular Cartilage Repair: Cartilage Autograft Implantation System Versus Conventional Microfracture
NCT01498029 ·Status: UNKNOWN ·Phase: PHASE3
-
Can Tendon Autograft Function As a Meniscal Transplant
NCT06858943 ·Status: COMPLETED ·Phase: NA
-
Prospective Trial of Arthroscopic Meniscectomy for Degenerative Meniscus Tears
NCT01931735 ·Status: COMPLETED ·Phase: NA
-
Evaluation of MRI Diagnosed Meniscal Lesions
NCT01492855 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Clinical-functional and Radiographic Outcomes in Patients Who Underwent Meniscal Allograft Transplantation (MAT) at 10 Years.
NCT06522152 ·Status: RECRUITING
-
DEMAND - DEgenerative Meniscal Tears - Arthroscopy vs. Dedicated Exercise
NCT02113280 ·Status: WITHDRAWN ·Phase: NA
-
Reconstruction of the Anterior Cruciate Ligament of the Knee Joint, by the Method of Stabilization of the Screw With a Bioabsorbable Method, With or Without the Use of Autogenous Spongiform Bone Grafts.
NCT05328544 ·Status: UNKNOWN ·Phase: NA
-
Knee Osteotomy Associated With Allograft Meniscus Transplantation
NCT05840887 ·Status: RECRUITING ·Phase: NA
-
Autologous Bone Marrow Aspirate Concentrate in Patients Undergoing Meniscectomy
NCT02582489 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Autologous Adipose Tissue Derived Mesenchymal Stem Cells Therapy for Patients With Knee Osteoarthritis
NCT01809769 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration
NCT04821102 ·Status: UNKNOWN ·Phase: NA
-
A Comparative Prospective Study of the Arthroscopic Meniscal Repair Methods
NCT06176183 ·Status: RECRUITING ·Phase: NA
-
Autologous Cell-derived Tissue Engineered Cartilage for Repairing Articular Cartilage Lesions
NCT02770209 ·Status: UNKNOWN ·Phase: NA
-
Autologous, Micro-fragmented Adipose Tissue for Meniscal Tears
NCT03714659 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Treatment of Osteoarthritis of the Knee in the Form of Chondromalacia of the Articular Cartilage Treated in the Arthroscopic Technique With the Use of:Autogenous Transplantation of Fragmented Adipose Tissue,PRP GF,Mesenchymal Cells,Hyaluronic Acid-low Molecular Weight and Cross-linked
NCT07110402 ·Status: COMPLETED ·Phase: NA
-
Effect of Autologous Peripheral Blood Stem Cell Treatment on Articular Cartilage Regeneration
NCT01076673 ·Status: COMPLETED ·Phase: PHASE2
-
Platelet-rich Plasma for Meniscus Repair
NCT03176641 ·Status: COMPLETED ·Phase: NA
-
A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
NCT00225095 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mesenchymal Stromal Cells for Degenerative Meniscus Injury
NCT02033525 ·Status: COMPLETED ·Phase: PHASE1/PHASE2